TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/18/24 16:12 | 12/17/24 | ESPR | Esperion Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Koenig Sheldon L. | MI | DO | P,CEO | S | -31 | 2.47 | 0 | -12 | -2 | 740 | D | ||||||||||||||
9/18/24 16:12 | 9/17/24 | ESPR | Esperion Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Koenig Sheldon L. | MI | DO | P,CEO | S | -26 | 1.80 | 0 | -15 | -2 | 752 | D | ||||||||||||||
3/20/23 16:16 | 3/17/23 | ESPR | Esperion Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Koenig Sheldon L. | MI | DO | P,CEO | S | -12 | 1.78 | 0 | -7 | -2 | 293 | D | ||||||||||||||
3/8/23 16:21 | 3/7/23 | ESPR | Esperion Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Koenig Sheldon L. | MI | DO | P,CEO | S | -28 | 5.06 | 0 | -5 | -3 | 195 | D | ||||||||||||||
9/20/22 16:08 | 9/19/22 | ESPR | Esperion Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Koenig Sheldon L. | MI | DO | P,CEO | S | -24 | 6.94 | 0 | -3 | -2 | 198 | D | ||||||||||||||
6/21/22 16:07 | 6/17/22 | ESPR | Esperion Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Koenig Sheldon L. | MI | DO | P,CEO | S | -23 | 4.99 | 0 | -5 | -2 | 190 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |